RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons

202511 citationsJournal Articlegreen Open Access

Authors

Diya Surie · Centers for Disease Control and Prevention

Wesley H. Self · Vanderbilt University Medical Center

Katharine A. Yuengling · Centers for Disease Control and Prevention

Adam S. Lauring · University of Michigan

Yuwei Zhu · Vanderbilt University Medical Center

Basmah Safdar · Yale University

Adit A. Ginde

Abstract

Respiratory syncytial virus vaccines prevented RSV-associated hospitalization during 2 seasons, although effectiveness was lower in patients with immunocompromise and cardiovascular disease than in those without these conditions. Ongoing monitoring is needed to determine the optimal RSV revaccination interval.

Topics & Keywords

Respiratory viral infections research Pneumonia and Respiratory Infections Influenza Virus Research Studies

Publication Details

Published in: JAMA

Volume 334, Issue 16, pp. 1442-1442

DOI: 10.1001/jama.2025.15896

Field-Weighted Citation Impact: 14.54

Command Palette

RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons

Authors

Abstract

Topics & Keywords

Publication Details